{"version":"1.0","type":"link","title":"Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.","author_name":"Traphagen NA 외","author_url":"https://prs-insight.online/author/Traphagen%20NA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/132334","thumbnail_width":1200,"thumbnail_height":630}